Gastroenterology
An altered metasystem linking the gut microbiota and systemic immune response could lead to impaired host defense and increased vulnerability to hospital-acquired infections in cases of severe illness.
A recent study shows that microbiota maturation during weaning contributes to normal immune development and protection from infection.
ETX-producing C. perfringens strains are biologically plausible pathogens in MS that trigger inflammatory demyelination.
The findings of a recent study identified microbiota signatures that may allow clinicians to predict the outcomes of CAR-T immunotherapy.
The findings of a recent study reveal that P. distasonis and its metabolites could be promising candidates for treating RA.
Diet-induced changes in the gut microbiota confer protection against respiratory infections by regulating the development of key components of the immune system.
Numerous evidences demonstrate the involvement of the sex hormone-gut microbiome axis in regulating the antitumor efficacy of ICIs.
The findings of a recent study suggest that other gut microbes use liquid-liquid phase separation to colonize the gut, opening the way for new microbiota-based clinical applications.
The findings of a recent study suggest that estradiol-degrading bacteria could be therapeutic targets for treating depression in some women.
The findings of a recent study suggest that tilimycin-producing bacteria can cause genetic mutations in the colon and increase a person’s susceptibility to disease.
